Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2025)
Roivant Sciences (ROIV) reported Amortizatization of Intangibles of $29.6 million for Q4 2025, down 45.48% on a YoY basis from $54.3 million in Q4 2024, and up 512.57% quarter-over-quarter from -$7.2 million in Q3 2025.
Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
Roivant Sciences has reported Amortizatization of Intangibles for 5 years, with the latest figure at $29.6 million in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 45.48% year-over-year to $29.6 million; the trailing twelve-month figure through Dec 2025 stood at $87.8 million (up 52.78% YoY), and the FY2026 full-year result was $8.3 million, up 20.94% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $29.6 million, up from -$7.2 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $54.3 million in Q4 2024, with the low at -$7.2 million in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $10.0 million across 5 years, with a median of $3.2 million in 2024.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 86.32% — and 2025, when it tumbled 327.09%.
- Roivant Sciences' Amortizatization of Intangibles stood at $5.4 million in 2021, then grew by 11.2% to $6.0 million in 2022, then slumped by 71.78% to $1.7 million in 2023, then jumped by 3101.89% to $54.3 million in 2024, then sank by 45.48% to $29.6 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $29.6 million (Q4 2025), -$7.2 million (Q3 2025), and $11.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.61 Mn |
| Dec 31, 2025 | 29.61 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Dec 31, 2024 | 54.30 Mn |
| Dec 31, 2024 | 54.30 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |